Docetaxel for treatment of solid tumours: a systematic review of clinical data

This publication has 34 references indexed in Scilit:

• Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial
  Journal of Clinical Oncology, 2004
• Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study
  Journal of Clinical Oncology, 2004
• The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
  Journal of Clinical Oncology, 2003
• Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
  Journal of Clinical Oncology, 2003
• Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel
  Journal of Clinical Oncology, 2002
• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
  The Lancet, 2001
• A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis
  European Journal Of Cancer, 2001
• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI Journal of the National Cancer Institute, 2000
• Risks and Benefits of Taxanes in Breast and Ovarian Cancer
  Drug Safety, 2000
• Promotion of microtubule assembly in vitro by taxol
  Nature, 1979